Capecitabine for ovarian cancer – pro

Capecitabine is an active agent for the treatment of patients with ovarian cancer previously treated with platinum and taxanes.

Vasey PA, McMahon L, Paul J, Reed N, Kaye SB. A phase II trial of capecitabine (Xeloda) in recurrent ovarian cancer. Br J Cancer. 2003 Nov 17;89(10)

Overview of the Updated NCCN Guidelines on Ovarian Cancer, Journal of Clinical Pathways September 2022
Volume 8 Issue 6

NCCN Ovarian Cancer 2022

Categories

Blog Archives